Eli Lilly and Company (NYSE:LLY).
Raymond James & Associates increased its position in Eli Lilly and Company stock by 349,228 shares in the quarter ending 09/30/2017. Its stake was valued at $31,234,000 an increase of $31,203,000 according to the filing.
Here are some institutional investors who have increased or decreased their stake in (LLY). As of the end of the quarter Commonwealth Of Pennsylvania Public School Empls Retrmt SYS had bought a total of 6,657 shares growing its position 9.2%. The value of the investment in (LLY) increased from $5,937,000 to $6,740,000 increasing 13.5% for the reporting period. As of quarter end Tredje Ap-fonden had disposed of 1,737 shares trimming its stake by 1.0%. The value of the company’s investment in Eli Lilly and Company went from $15,006,000 to $15,448,000 a change of $442,000 since the last quarter.
As of quarter end Baird Financial Group, Inc. had disposed of a total of 900 shares trimming its holdings by 0.3%. The value of the investment in Eli Lilly and Company went from $21,974,000 to $22,762,000 a change of 3.6% quarter over quarter.
BMO Capital Markets updated guidance on LLY stating a rating of “Sell” and setting a price target of $73.00. October 26 investment analysts at Berenberg Bank made no change to the company rating of “Buy” projecting a price of $98.00.
Equity analyst BMO Capital Markets issued a report on LLY with a rating of “Sell” and a price target of $73.00. Leerink Swann raised the price target of the stock on October 23 changing the price objective from $92.00 to $93.00 and issued a “Market Perform” rating.
On October 16 analysts at BMO Capital Markets updated coverage of LLY and giving a rating of “Sell” and establishing a price target of $73.00. Equity analyst Barclays PLC raised the price target on October 13 boosting the projection from $90.00 to $98.00 and stated a “Overweight” rating.
The company is now down from yesterday’s close of 82.5. The company’s P/E ratio is 39.24 and market capitalization is 90.75B. In the last earnings report the EPS was $2.10 with 1.10B shares outstanding.
Investors are a little more bullish on shares of the company if you take a look at the change in short interest. The stock saw a fall in short interest of -22.71% as of October 31, 2017 from the last reporting period. Short interest decreased from 12,644,571 to 9,772,748 over that period. With short interest at 9,772,748 and short average daily volume at 4,221,711, the short-interest ratio is 2.0 and the percentage of shorted shares was 0.01% on October 31.